Details for Patent: 6,288,095
✉ Email this page to a colleague
Summary for Patent: 6,288,095
Title: | Compounds |
Abstract: | A method is provided for the treatment and/or prophylaxis of cardiovascular diseases or eating disorders in a human or non-human mammal, which comprises administering to a human or non-human mammal in need thereof, an effective, non-toxic amount of a compound of formula (I): ##STR1## or a tautomeric form thereof and/or a pharmaceuticlaly acceptable salt thereof and/or a pharmaceutically acceptable solvate thereof, in which A.sup.1 represents a substituted or unsubstituted aromatic heterocyclyl group; R.sup.1 represents a hydrogen atom, an alkyl group, an acyl group, an aralkyl group, wherein the aryl moiety may be substituted or unsubstituted, or a substituted or unsubstituted aryl group; R.sup.2 and R.sup.3 each represent hydrogen, or R.sup.2 and R.sup.3 together represent a bond; A.sup.2 represents a benzene ring having in total up to five substituents; and n represents an integer in the range of from 2 to 6. |
Inventor(s): | Hindley; Richard Mark (Epsom, GB), Cawthorne; Michael Antony (Epsom, GB) |
Assignee: | Beecham Group p.l.c. (GB) |
Application Number: | 08/358,327 |
Patent Claim Types: see list of patent claims | Use; Composition; Process; Dosage form; |
Drugs Protected by US Patent 6,288,095
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,288,095
International Family Members for US Patent 6,288,095
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 0306228 | ⤷ Sign Up | SPC/GB01/002 | United Kingdom | ⤷ Sign Up |
European Patent Office | 0306228 | ⤷ Sign Up | 2001C/004 | Belgium | ⤷ Sign Up |
European Patent Office | 0306228 | ⤷ Sign Up | C300034 | Netherlands | ⤷ Sign Up |
European Patent Office | 0306228 | ⤷ Sign Up | 38/2000 | Austria | ⤷ Sign Up |
Austria | 186724 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |